Hyperbaric Oxygen Treatment for LONG-COVID, called HOT-LoCo; an examination of the LONG post COVID-19 syndromes (especially residual pulmonary disease) by Dr. Peter McCullough (Courageous Discourse)

by Paul Alexander

People are suffering now and begging for something to deal with LONG-COVID weakness, depression, muscle fatigue and loss of mass, hair loss, sleep disturbance, anosmia, tinnitus, headaches etc.

Dr. McCullough (see his substack) raises very critical issues here and I wanted to share some information and unpack this a bit more. The LONG-COVID symptoms are real, either due to the virus that you have recovered from, or the ravages of the COVID gene injection vaccine, whether mRNA or DNA platforms. LONG-COVID is real. Our argument has been that the gene injection vaccine drives debilitating symptoms akin to post viral infection and for some it is life-altering and can even be destructive.

One may argue that hyperbaric oxygen treatment for LONG-COVID is still nascent and emerging yet the principle seems sound. The issue really is that of cost (can be prohibitively expensive), accessibility, and practicality for it is indeed safe. No doubt we need more rigorous study with proper randomized controlled trials to tease out cause. Yet what has emerged thus far is promising. Cost really is the rate limiting step and the time to invest in the treatment, as currently offered.


McCullough supports this treatment approach for LONG-COVID and I too see benefit. I join him in calling for more rigorous study, optimally via large sample sized randomized clinical trials. This approach needs further study and serious consideration.

The following studies should give some more background:

Zilberman-Itskovich, S., Catalogna, M., Sasson, E. et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep 12, 11252 (2022). https://doi.org/10.1038/s41598-022-15565-0

Kjellberg A, Abdel-Halim L, Hassler A, El Gharbi S, Al-Ezerjawi S, Boström E, Sundberg CJ, Pernow J, Medson K, Kowalski JH, Rodriguez-Wallberg KA, Zheng X, Catrina S, Runold M, Ståhlberg M, Bruchfeld J, Nygren-Bonnier M, Lindholm P. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open. 2022 Nov 2;12(11):e061870. doi: 10.1136/bmjopen-2022-061870. PMID: 36323462; PMCID: PMC9638753.


Courageous Discourse™ with Dr. Peter McCullough & John Leake
Hyperbaric Oxygen for Treatment of Long COVID-19 Syndrome (HOT-LoCO)
By Peter A. McCullough, MD, MPH Many followers have been clamoring for some approach to post-COVID-19 syndromes. I have tried many therapies in clinical practice and have been disappointed with my observations. Approximately 50% of patients hospitalized with severe respiratory COVID-19 suffer from post-COVID-19 syndromes including weakness, depression…
Read more